{"product_id":"mrna-vaccines-9783031180712","title":"mRNA Vaccines","description":"\u003cp\u003e • Author(s): Dong Yu | Benjamin Petsch\u003cbr\u003e • Publisher: Springer\u003cbr\u003e • Publisher Imprint: Springer\u003cbr\u003e • BISAC: Immunology\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003e\u003cb\u003eForeword - RNA technology overview\u003c\/b\u003e\u003c\/p\u003eDong Yu (dong.x.yu@gsk.com) (GSK) \u0026amp; Frank B�hner (Frank.Baehner@curevac.com) (CureVac) - confirmed\u003cp\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eConventional mRNA-based technology \u0026amp; mode of action\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBenjamin Petsch (benjamin.petsch@curevac.com) (CureVac) - confirmed\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSelf-amplifying RNA-based technology \u0026amp; mode of action\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eJeffrey Ulmer (jeffrey.b.ulmer@gsk.com)\/Dong Yu (dong.x.yu@gsk.com) (GSK) - confirmed\u003c\/p\u003e \u003cp\u003e\u003cb\u003eDelivery and formulation technologies\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003eYizhou Dong (dong.525@osu.edu) (Ohio State) - confirmed\u003c\/p\u003e\u003cb\u003eRNA for infectious disease applications\u003c\/b\u003e\u003cp\u003e\u003c\/p\u003e \u003cp\u003eDrew Weissman (dreww@pennmedicine.upenn.edu) (U Penn) - confirmed\u003c\/p\u003e \u003cp\u003e\u003cb\u003eRNA for other indications (immunotherapies\/oncology, molecular therapies - a potential topic)\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eTim Wagenaar (Timothy.Wagenaar@sanofi.com) (Sanofi) - tentatively confirmed, likely working with Biotech; Backup - Katalin Karik� (BioNTech)\u003c\/p\u003e \u003cp\u003e\u003cb\u003eProduction and capabilities\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eHeinrich Haas (Heinrich.Haas@biontech.de) (Biontech) - waiting for response; Backup - Juan Andres (Moderna)\u003c\/p\u003e \u003cp\u003e\u003cb\u003eClinical development\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eTal Zaks (Tal.Zaks@modernatx.com) (Moderna) - tentatively confirmed; Backup - Anna Coll�n (AstraZeneca)\u003c\/p\u003e \u003cp\u003e\u003cb\u003eOther considerations (e.g., safety, regulatory issues, challenges)\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003eMark Tracy (mark@tracybioconsulting.com) (Tracy Bioconsulting) - waiting for response\u003c\/p\u003e","brand":"Springer","offers":[{"title":"Paperback","offer_id":47888704536727,"sku":"9783031180712","price":5096.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0666\/3471\/1191\/files\/9783031180712.webp?v=1781167742","url":"https:\/\/atlanticbooks.com\/products\/mrna-vaccines-9783031180712","provider":"Atlantic Books","version":"1.0","type":"link"}